 产品搜索 |
| 产品类别 |
| 推荐产品 |
 叔丁基二甲基氯硅烷 |
| 2-氯-4,6-二甲基吡啶 |
| 2-溴-4,6-二甲基吡啶 |
| 6-氯苯并三氮唑-1,1,3,3- |
| 1,3-二苯基异苯并呋喃 |
| 培哚普利 |
| 9-(4-乙酰氧基-3-乙酰氧 |
| 嘧啶-5-硼酸 |
| 2-氯-3-硝基-4-甲基吡啶 |
| 7-氮杂吲哚 |
| 4-氮杂吲哚 |
| 5-氮杂吲哚 |
| 6-氮杂吲哚 |
| 7-azaoxindole |
| 6-azaoxindole |
| 4-叔丁基苯硼酸 |
| D-氨基半乳糖盐酸盐 |
| N-乙酰基-D-氨基半乳糖 |
| 溴代葡萄糖苷 |
| 利培酮 |
| N-三氟乙酰基-L-赖氨酸 |
| N2-(1-乙氧羰基-3-苯丙基 |
| N2-[1-(S)-乙氧羰基-3-苯 |
| 3-氨基甲酰基苯硼酸 |
| 2,4-二氯-6-甲基嘧啶 |
| N-(4-氨基丁基)-N-乙基异 |
| AOP |
| BOP |
| 4,4-二甲氧基三苯甲基 |
| 2-氯-1-甲基吡啶碘盐 |
| HOTT |
| TSTU |
| 1-(4-甲磺基)-3-硝基-1,2,4 |
| TPTU |
| 2,4,6-三异丙基苯磺酰氯 |
| TOTU |
| TOTT |
| TNTU |
| TFFH |
| TDBTU |
| TCTU |
| TCFH |
| TBTU |
| TATU |
| N-Hydroxysulfosuccinimide sodi |
| 8-喹啉磺酰氯 |
| PyCloP |
| PYCLU |
| PyBroP |
| PyBOP |
|
| 产品展示 |
| 产品编号 |
产品名称 |
CAS No. |
含量 |
| W15959 | 5-[3-[2-(4-morpholinyl)-4-pyrimidinyl]-1H-indol-5-yl]-1,3,4-Thiadiazol-2-amine | 1401346-58-4 | 95% |
| W15960 | N-methyl-5-[3-[4-(4-methyl-1-piperazinyl)-2-pyrimidinyl]-1H-indol-5-yl]-1,3,4-Thiadiazol-2-amine | 1401346-57-3 | 95% |
| W15961 | N-methyl-5-[3-(4-phenyl-2-pyrimidinyl)-1H-indol-5-yl]-1,3,4-Thiadiazol-2-amine | 1401346-56-2 | 95% |
| W15962 | 5-[3-(6-phenyl-2-pyridinyl)-1H-indol-5-yl]-1,3,4-Thiadiazol-2-amine | 1401346-55-1 | 95% |
| W15963 | 5-[3-[1-[2-(4-morpholinyl)ethyl]-1H-pyrazol-4-yl]-1H-indol-5-yl]-1,3,4-Oxadiazol-2-amine | 1401346-08-4 | 95% |
| W15964 | 5-[3-[1-(2-methylpropyl)-1H-pyrazol-4-yl]-1H-indol-5-yl]-1,3,4-Oxadiazol-2-amine | 1401346-07-3 | 95% |
| W15965 | 5-[3-[6-(1H-pyrazol-1-yl)-2-pyridinyl]-1H-indol-5-yl]-1,3,4-Oxadiazol-2-amine | 1401346-04-0 | 95% |
| W15966 | 5-(3-(6-isopropoxypyrazin-2-yl)-1H-indol-5-yl)-1,3,4-oxadiazol-2-amine | 1401346-03-9 | 95% |
| W15967 | 5-[3-[6-(4-methyl-1-piperazinyl)-2-pyridinyl]-1H-indol-5-yl]-1,3,4-Oxadiazol-2-amine | 1401346-02-8 | 95% |
| W15968 | 6-(5-(5-amino-1,2,4-oxadiazol-3-yl)-1H-indol-3-yl)-N-isopropylpyrazin-2-amine | 1401345-97-8 | 95% |
| W15969 | 5-[3-[6-(4-morpholinyl)-2-pyridinyl]-1H-indol-5-yl]-1,3,4-Thiadiazol-2(3H)-one | 1401345-36-5 | 95% |
| W15970 | 3-[6-(4-morpholinyl)-2-pyridinyl]-5-(1,3,4-thiadiazol-2-yl)-1H-Indole | 1401345-35-4 | 95% |
| W15971 | 5-(5-bromo-1,3,4-thiadiazol-2-yl)-3-[6-(4-morpholinyl)-2-pyridinyl]-1H-Indole | 1401345-34-3 | 95% |
| W15972 | N,N-dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-Pyrazinamine | 1311412-96-0 | 95% |
| W15973 | 2-(3-methyl-1H-pyrazol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Pyrazine | 1310405-10-7 | 95% |
| W15974 | 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2(1H)-Pyridinone | 1310405-04-9 | 95% |
| W15975 | 2-(cyclobutyloxy)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Pyridine | 1310404-15-9 | 95% |
| W15976 | 2-(3-methyl-1-piperidinyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Pyridine | 1310404-13-7 | 95% |
| W15977 | 2-(3-methyl-1H-pyrazol-1-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Pyridine | 1310404-12-6 | 95% |
| W15978 | 2-ethoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Pyridine | 1310385-03-5 | 95% |
| W15979 | 2-methyl-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-thiazolyl]Piperidine | 1310383-64-2 | 95% |
| W15980 | 2-(4-methyl-1-piperidinyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Pyridine | 1310383-51-7 | 95% |
| W15981 | 2-(cyclohexyloxy)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Pyridine | 1310383-05-1 | 95% |
| W15982 | 1-methyl-4-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]Piperazine | 1310383-04-0 | 95% |
| W15983 | 2-propoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Pyridine | 1309982-31-7 | 95% |
| W15984 | 2-(2-methyl-1-piperidinyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Pyridine | 1309982-28-2 | 95% |
| W15985 | 2-(1-piperidinyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Pyrazine | 1309981-53-0 | 95% |
| W15986 | 3-iodo-1H-Indole-5-carboxylic acid | 1308644-52-1 | 95% |
| W15987 | 4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyrazinyl]Morpholine | 1283180-64-2 | 95% |
| W15988 | 2-(1-pyrrolidinyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Pyrazine | 1283179-52-1 | 95% |
|
|
|
|
